Baird Medical Investment Limited
BDMD | NASDAQ
$0.79
-$0.05 (-6.05%)
Sep 22, 2026, 2:13 PM ET · Market open
Market Data
Market Cap $35.49M
Enterprise Value $49.43M
Beta -1.14
Average Volume 112.02K
Shares Outstanding (Diluted) 40.98M
Shares Change YoY 448.49%
Institutional Ownership N/A
Exchange NASDAQ
ISIN KYG0705H1039
Price Performance
Price Change 1M -26.3%
Price Change 3M -17.6%
Price Change 6M -62.0%
Price Change YTD -37.3%
Price Change 1Y -66.5%
Price Change 3Y -92.1%
Price Change 5Y -91.4%
1M CAGR (ann.) -31.1%
1Y CAGR (ann.) -67.3%
5Y CAGR (ann.) N/A
All-Time CAGR -40.1%
Valuation
PE Ratio -1.53
Forward PE 9.12
PEG Ratio 0.00
Forward PEG -0.02
PS Ratio 1.45
Forward PS 1.10
PB Ratio 1.02
P/FCF Ratio -25.60
P/Adj. FCF Ratio -25.60
P/OCF Ratio 16.80
EV/Sales 2.02
EV/EBIT -3.45
EV/EBITDA -3.61
EV/FCF -35.65
Earnings Yield -65.5%
FCF Yield -3.9%
Adj. FCF Yield -3.9%
Financial Health
Net Debt $13.93M
Total Debt $14.22M
Cash & Short-Term Investments $289.08K
Total Assets $73.85M
Current Ratio 1.29
Quick Ratio 1.26
Debt / Equity Ratio 0.41
Debt / EBITDA -1.04
Debt / FCF -10.26
OCF / Debt -0.09
Interest Coverage -20.07
Altman Z-Score 0.39
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 85.6%
Operating Profit Margin -58.5%
EBITDA Margin -53.2%
Net Profit Margin -65.2%
FCF Margin -5.7%
Adj. FCF Margin -5.7%
SBC / Revenue 9.7%
SBC Impact (per share) N/A
Returns
Return on Assets -21.6%
Return on Equity -48.3%
Return on Invested Capital -27.0%
Return on Capital Employed -36.8%
Return on Tangible Assets -21.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -13.7%
Revenue CAGR 5Y 4.5%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -2606.3%
EPS CAGR 5Y -159.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y 24.0%
FCF CAGR 5Y -44.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Sep 2, 2026
EPS Estimate (next Q) $0.04
EPS Growth Est (next Q) N/A
Revenue Est (next Q) $12M
Revenue Growth Est (next Q) 50.8%
Cash Flow
Operating Cash Flow $-1.34M
Free Cash Flow $-1.39M
Adj. Free Cash Flow $-1.39M
FCF Per Share $0.05
OCF Per Share $0.05
OCF/S Ratio 7.6%
Income Statement
Revenue $24.49M
Gross Profit $20.97M
Operating Income $-14.33M
EBITDA $-13.71M
Net Income $-15.97M
EPS (Diluted) -$0.55
Revenue / Employee $167.76K
Profit / Employee $-109.39K
Employees 146
Add to Watchlist
Select watchlists to add or remove BDMD